Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Skovsgaard

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Anti-Cancer Drugs|June 23, 1998
Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugsJ Gehl, T Skovsgaard, L M Mir
Cancer Treatment Reviews|March 1, 1984
Chemosensitizers counteracting acquired resistance to anthracyclines and vinca alkaloids in vivo. A new treatment principleT Skovsgaard, K Danø, N I Nissen
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Anthracycline resistanceE Friche, T Skovsgaard, N I Nissen
Cancer Chemotherapy and Pharmacology|January 1, 1987
Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cellsE Friche, T Skovsgaard, N I Nissen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patientsB V Jensen, T Skovsgaard, S L Nielsen
Cancer Treatment Reports|May 1, 1985
Treatment of small cell lung cancer with 6-mercaptopurine: a phase II studyS W Hansen, T Skovsgaard, J B Sørensen
Lancet (London, England)|February 3, 1996
Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathyB V Jensen, S L Nielsen, T Skovsgaard
International Review of Cytology|January 1, 1994
Cellular resistance to cancer chemotherapyT Skovsgaard, D Nielsen, C Maare, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Increased uptake of actinomycin D in Ehrlich ascites tumour cells induced by daunorubicinC Lund-Andersen, T Skovsgaard, N I Nissen
Cancer Treatment Reports|March 1, 1983
Intermittent high-dose aclarubicin in patients with advanced cancer: a phase I study with special reference to cardiac toxicityK Aabo, S A Mortensen, T Skovsgaard, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Anti-Cancer Drugs|June 23, 1998
Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugsJ Gehl, T Skovsgaard, L M Mir
Cancer Treatment Reviews|March 1, 1984
Chemosensitizers counteracting acquired resistance to anthracyclines and vinca alkaloids in vivo. A new treatment principleT Skovsgaard, K Danø, N I Nissen
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Anthracycline resistanceE Friche, T Skovsgaard, N I Nissen
Cancer Chemotherapy and Pharmacology|January 1, 1987
Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cellsE Friche, T Skovsgaard, N I Nissen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patientsB V Jensen, T Skovsgaard, S L Nielsen
Cancer Treatment Reports|May 1, 1985
Treatment of small cell lung cancer with 6-mercaptopurine: a phase II studyS W Hansen, T Skovsgaard, J B Sørensen
Lancet (London, England)|February 3, 1996
Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathyB V Jensen, S L Nielsen, T Skovsgaard
International Review of Cytology|January 1, 1994
Cellular resistance to cancer chemotherapyT Skovsgaard, D Nielsen, C Maare, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1983
Increased uptake of actinomycin D in Ehrlich ascites tumour cells induced by daunorubicinC Lund-Andersen, T Skovsgaard, N I Nissen
Cancer Treatment Reports|March 1, 1983
Intermittent high-dose aclarubicin in patients with advanced cancer: a phase I study with special reference to cardiac toxicityK Aabo, S A Mortensen, T Skovsgaard, et al.
Pageof 8